Global Continuous Renal Replacement Therapy (CRRT) Market is poised to grow at a CAGR of 7 to 9% by 2027

Continuous Renal Replacement Therapy (CRRT) is a slow and gentle form of dialysis which removes the additional fluids and waste products from blood in a continuous manner, similar to the way the kidneys function in healthy people. 

Adoption of CRRT for the Treatment of Severely Sick Patients with Acute Kidney Injury (AKI) Fuels its Worldwide Growth

AKI is a global kidney problem and is most common among severely sick patients. It is projected that around 13.3 million people across the world are suffering from AKI yearly, ~85% of whom live in developing regions. The major objective of CRRT for severely sick patients with AKI problems are maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without any further risk or complication.

Major Advantages Associated with CRRT Triggers the Growth of the Continuous Renal Replacement Therapy Market

Hemodynamic instability is common among the severely sick patients with AKI receiving RRT. CRRT may have a better hemodynamic profile as compared with other intermittent therapies, such as intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the CRRT’s major advantages, is the prevention of changes in intracerebral water. CRRT is also considered much safer than IHD in patients at risk of cerebral edema.

Increasing Awareness on the Kidney Health & Prevention Programs Drives the Growth of the CRRT Market 

Presently, a huge number of kidney health & prevention programs are been run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP), and local governments across the world to increase the awareness on evidence-based interventions to enrich understanding, detection, and management of various kidney diseases. 

Impact of Covid-19 on the Global CRRT Market

Globally, all the healthcare systems had been affected by COVID-19 pandemic. During covid-19, approximately 15%-30% of patients with COVID-19 admitted to the ICU were exhibiting signs of kidney failure and they required CRRT. In such scenarios, CRRT acted as a life-saving therapy for the patients.

Upcoming Market Challenges for CRRT Market

The higher costs of the CRRT procedures and the various risks & complications associated with CRRT such as catheter-related complications, blood loss, infection or access failure, fluctuations in salt balance, hemodialysis-related complications, coagulopathy, and venous thrombosis, etc. may impact the growth of the continuous renal replacement therapy market in the coming years. 

North America Accounts for the Larger Market Share in the Continuous Renal Replacement Therapy Market

From a geographical outlook, North America accounts for the larger market share in the global continuous renal replacement therapy market. This can be mainly attributed to the growing number of AKI, rapid developments in continuous renal replacement therapy products, and a rapid surge in the number of diabetic patients in North America. 

Competitive Landscape Analysis: Continuous Renal Replacement Therapy Market

Some of the leading and promising players operating in the global continuous renal replacement therapy market are Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, and Nipro Corporation, etc.

Aggressive Growth Strategies Adopted by the Leading Market Players to Establish Their Foothold in the CRRT Market

All the top and leading players operating in the global continuous renal replacement therapy market are adopting both organic and inorganic growth strategies such as collaborations and partnerships, acquisitions, and new product launches to gain a higher market share in the global market. 

For instance,

  • In August 2022, Fresenius Medical Care closed a three-way merger including Fresenius Health Partners, the value-based care division of Fresenius Medical Care North America, and created a premier value-based kidney care provider in United States.
  • In April 2022, Baxter International Inc. announced the US FDA 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy.

Get Detailed Insights on Continuous Renal Replacement Therapy (CRRT) Market @ https://meditechinsights.com/continuous-renal-replacement-therapy-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more